000 05270naaaa2201309uu 4500
001 https://directory.doabooks.org/handle/20.500.12854/40131
005 20220220092036.0
020 _abooks978-3-03928-587-7
020 _a9783039285860
020 _a9783039285877
024 7 _a10.3390/books978-3-03928-587-7
_cdoi
041 0 _aEnglish
042 _adc
100 1 _aBüchler, Christa
_4auth
245 1 0 _aAdipokines 2.0
260 _bMDPI - Multidisciplinary Digital Publishing Institute
_c2020
300 _a1 electronic resource (406 p.)
506 0 _aOpen Access
_2star
_fUnrestricted online access
520 _aOnce viewed solely as fat storage cells, adipocytes and their adipokines have now been proven to be central for human health. Understanding that overweight and obesity may increase the risk for various diseases requires detailed characterization of adipokine function. Weight gain, weight regain, and fasting affect adipocyte health and accordingly their secretome. Different adipose tissue deposits exist and they vary in cellular composition and function. The evidence is strong of a role of adipokines in cancer, reproductive function, neurological diseases, cardiovascular diseases ,and rheumatoid arthritis. Adipokines are considered useful biomarkers for adipose tissue and metabolic health, and may be used as diagnostic tools in rheumatoid arthritis, cancer, or sepsis. This book contains 10 original articles and 9 review articles focusing on these bioactive peptides. Several articles deal with chemerin, an adipokine discovered more than 20 years ago. Data so far have resulted in promising insights related to its biological function. We are only beginning to understand the multiple roles of chemerin, the mechanisms regulating its activity, and the signaling pathways used by this chemokine. Adipokine receptor agonists and antagonists may result in the formulation of novel drugs and ultimately may lead to new therapeutic targets to be used in clinical practice.
540 _aCreative Commons
_fhttps://creativecommons.org/licenses/by-nc-nd/4.0/
_2cc
_4https://creativecommons.org/licenses/by-nc-nd/4.0/
546 _aEnglish
653 _an/a
653 _alipids
653 _acathepsins
653 _aneurodegeneration
653 _atocilizumab
653 _aSGBS adipocytes
653 _achemerin receptors
653 _acholesterol
653 _ametabolically healthy obese
653 _aenergy metabolism
653 _aadipose-brain axis
653 _aEP3 receptor
653 _aleptin
653 _arheumatoid arthritis
653 _aexcessive gestational weight gain
653 _ain vitro fat regain
653 _asecreted frizzled-related protein 5
653 _aPCOS
653 _aEP4 receptor
653 _aleukocyte
653 _aexchange protein directly activated by cAMP isoform 2 (EPAC2)
653 _aextracellular remodeling
653 _ainsulin
653 _aosteoarthritis
653 _alipid metabolism
653 _afat mass
653 _aTango bioassay
653 _afatty liver
653 _afree fatty acids
653 _alabel-free proteomic profiling
653 _ainterleukin(IL)-33
653 _asick fat
653 _apolycystic ovary syndrome
653 _aearly-life programming
653 _ainflammation
653 _agestational diabetes
653 _aglucose restriction
653 _aadipokines
653 _aneonatal anthropometry
653 _aepicardial adipose tissue (EAT)
653 _aoestrous cycle
653 _aCardiovascular Diseases (CVDs)
653 _atriglycerides
653 _aG protein-coupled receptor 1
653 _atesticular pathologies
653 _aprognosis
653 _aovary
653 _aICU
653 _abiologic activity
653 _apreeclempsia
653 _aadipokine
653 _acritical illness
653 _aearly pregnancy
653 _amyokine
653 _aliver steatosis
653 _aC-C chemokine receptor-like 2
653 _atestis
653 _astimulating growth factor 2 (ST2)
653 _apig
653 _afitness
653 _ahuman granulosa cells
653 _aobesity
653 _aproteolysis
653 _aannexins
653 _aadipose tissue
653 _abiomarker
653 _aghrelin
653 _abrain health
653 _asepsis
653 _aadiponectin
653 _arheumatic diseases
653 _achemokine-like receptor 1
653 _afollicular fluid
653 _aglucose homeostasis
653 _aresistin
653 _aNonalcoholic fatty liver disease
653 _aprostaglandin E2 (PGE2)
653 _avisceral fat
653 _amicroglia
653 _aweight regain
653 _acomplement factors
653 _aalpha-fetoprotein
653 _apolycystic ovary morphology
653 _achemerin
653 _acancer
653 _adepression
653 _ahypertension
653 _ahypothalamus
856 4 0 _awww.oapen.org
_uhttps://mdpi.com/books/pdfview/book/2157
_70
_zDOAB: download the publication
856 4 0 _awww.oapen.org
_uhttps://directory.doabooks.org/handle/20.500.12854/40131
_70
_zDOAB: description of the publication
999 _c78308
_d78308